BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2018

Jan 5, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2018-01-02

Reporting Person: LAWLIS V BRYAN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-02	Common Stock	M	3750	$38.59	Acquired	18610	Direct
2018-01-02	Common Stock	S	3750	$88.84	Disposed	14860	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-02	Stock Option (right to buy Common Stock)	$38.59	M	3750	Disposed	2018-05-21	Common Stock (3750)	Direct

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

F2: Amount of securities beneficially owned has been updated from the reporting person's prior report to exclude 1,050 shares as previously reported in the Form 4 Amendment filed with the S.E.C. on 10/13/2017.

F3: All shares sold at the same price.

F4: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.